{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:16:46Z","timestamp":1790543806962,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejso.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T11:29:18Z","timestamp":1224847758000},"page":"475-480","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors"],"prefix":"10.1016","volume":"35","author":[{"given":"G.P.","family":"Clunie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Melton LJ III. Hip fractures in the elderly: a worldwide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporosis Int"},{"issue":"2","key":"10.1016\/j.ejso.2008.08.001_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/BMM:3:2:157","article-title":"Aging bones: osteoporosis and injurious falls in the oldest women","volume":"3","author":"Heffernan","year":"2005","journal-title":"Clin Rev Bone and Miner Metab"},{"key":"10.1016\/j.ejso.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02508636","article-title":"Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population","volume":"58","author":"Miller","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ejso.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.bone.2007.03.003","article-title":"Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences","volume":"40","author":"Boonen","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ejso.2008.08.001_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7-8","key":"10.1016\/j.ejso.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjc.6690188","article-title":"A high incidence of vertebral fracture in women with breast cancer","volume":"79","author":"Kanis","year":"1999","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","article-title":"Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study","volume":"165","author":"Chen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.ejso.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/sj.bjc.6602691","article-title":"Bone loss and the aromatase inhibitors","volume":"93","author":"Lester","year":"2005","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.ejso.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2008.08.001_bib11","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl 2","key":"10.1016\/j.ejso.2008.08.001_bib12","first-page":"S1","article-title":"NCCN Task force report: bone health and cancer care","volume":"4","author":"Theriault","year":"2006","journal-title":"J Nat Comp Cancer Netw"},{"issue":"1","key":"10.1016\/j.ejso.2008.08.001_bib13","first-page":"13","article-title":"The Writing Group for the ISCD Position Development Conference. Position statement. Introduction, methods and participants","volume":"7","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.ejso.2008.08.001_bib14","series-title":"Position statement on the reporting of dual energy x-ray Absorptiometry (DXA) bone mineral density scans","author":"Fogelman","year":"2002"},{"key":"10.1016\/j.ejso.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00041552-200111000-00009","article-title":"Prediction equations to estimate glomerular filtration rate: an update","volume":"10","author":"Manjunath","year":"2001","journal-title":"Curr Opin Nephrol Hypertension"},{"key":"10.1016\/j.ejso.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2008.08.001_bib17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"8","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"17","key":"10.1016\/j.ejso.2008.08.001_bib18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.276.17.1404","article-title":"Bone Mineral Density and risk of breast cancer in older women: the study ofosteoporotic fractures. Study of osteoporotic fractures research group","volume":"276","author":"Cauley","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2008.08.001_bib19","article-title":"Osteoporosis Prevention","author":"NICE","year":"2007","journal-title":"Secondary Prevention: Final appraisal document"},{"issue":"8","key":"10.1016\/j.ejso.2008.08.001_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"The ATAC trialist's Group. Effect of an AI on BMD and bone turnover markers: 2-year results of the anastrozole, Tamoxifen alone or in combination (ATAC) trial","volume":"21","author":"Eastell","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.ejso.2008.08.001_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S8756-3282(03)00236-9","article-title":"Is the paradigm shifting?","volume":"33","author":"Heaney","year":"2003","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.ejso.2008.08.001_bib22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1359\/JBMR.050704","article-title":"Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study","volume":"20","author":"Sornay-Rendu","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.ejso.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Fracture risk in primary hyperparathyroidism","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ejso.2008.08.001_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00016340601033287","article-title":"Primary hyperparathyroidism is common in postmenopausal women with forearm fracture and low bone mineral density","volume":"86","author":"Bergstrom","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.ejso.2008.08.001_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ejso.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: are we ignoring the evidence?","volume":"89","author":"Zitterman","year":"2003","journal-title":"Br J Nutrition"},{"key":"10.1016\/j.ejso.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.ejca.2006.07.005","article-title":"Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomized placebo-controlled study","volume":"42","author":"Geisler","year":"2006","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798308017368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798308017368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:32:16Z","timestamp":1709339536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798308017368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0748798308017368"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2008.08.001","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}